がんにおける低酸素誘発の炎症性細胞死亡のメカニズム
PubMedで要約を見る
まとめ
この要約は機械生成です。PTP1Bの抑制はRNF213の活性化を誘発し,低酸素性乳がんでは炎症性細胞死を引き起こす. この経路は,CYLD/SPATA2の分解とNLRP3炎症体の活性化を含み,潜在的な治療目標を提供している.
科学分野
- 腫瘍学
- 分子生物学
- 免疫学
背景
- 低毒性がん細胞は治療に抵抗し,再発を促します.
- タンパク質チロシン・ファスファタゼ1B (PTP1B) 欠乏症/阻害はRNF213を活性化させ,低酸素状態のHER2陽性乳がんにおける細胞死を引き起こす.
- RNF213はモヤモヤ病,脂毒性,先天性免疫に関与する大きなタンパク質です.
研究 の 目的
- PTP1BとABL1/2によるRNF213の調節メカニズムを解明する.
- 低毒性腫瘍における炎症性細胞死経路の調節における PTP1B-RNF213軸の役割を調査する.
- 乳がんの潜在的治療標的を特定する.
主な方法
- PTP1BとABL1/2によるRNF213チロシン酸化の相互制御を調査した.
- 評価された RNF213 オリゴメリゼーションと RZ ドメインの活性化.
- RNF213 RZドメインによるCYLD/SPATA2の汎用化と分解を分析した.
- NF- kBの活性化とNLRP3炎症体の誘発を研究した.
- ヒトの表皮成長因子受容体2陽性乳がん異種移植において,CYLDとNLRP3のデレーションモデルを使用した.
- 溶解試験にRNF213変異体を使用した.
主要な成果
- PTP1BとABL1/ 2は,相互にRNF213チロシン酸化,オリゴメリゼーション,およびRZドメインの活性化を調節する.
- RNF213 RZドメインはCYLD/SPATA2の分解を誘導し,NF-κBの活性化とNLRP3炎症体の誘導につながる.
- NLRP3炎症体の活性化と結合した低酸素誘発の内プラズマ網膜のストレスは,炎症性の細胞死を引き起こします.
- CYLDの消去はPTP1Bの欠乏の抗腫瘍効果を模倣し,NLRP3の消去はブロックした.
- RNF213 RZドメインによる腫瘍細胞死は,再構成試験で確認された.
結論
- 低毒性腫瘍における炎症性細胞死制御に不可欠な新しいPTP1B-RNF213-CYLD-SPATA2経路が特定されました.
- RNF213の調節と癌におけるその役割に関する新しい洞察を提供した.
- この経路をターゲットにすることで 乳がんの潜在的治療効果を強調した.
- モヤモヤ病,炎症,自己免疫疾患に対する潜在的な関連性.
関連する概念動画
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...

